Characteristics and Prognostic Outcomes of Diaphragmatic Ultrasound in Myasthenia Gravis

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Myasthaenia Gravis
Trial Locations (1)

400016

The First Affiliated Hospital of Chongqing Medical University, Chongqing

All Listed Sponsors
lead

First Affiliated Hospital of Chongqing Medical University

OTHER

NCT06707727 - Characteristics and Prognostic Outcomes of Diaphragmatic Ultrasound in Myasthenia Gravis | Biotech Hunter | Biotech Hunter